NCT06722287 Mobile Intervention for Mental Health of Family Caregivers in Thailand
| NCT ID | NCT06722287 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Brigham and Women's Hospital |
| Condition | Depressive Symptoms, Generalized Anxiety, or Psychological Stress |
| Study Type | INTERVENTIONAL |
| Enrollment | 400 participants |
| Start Date | 2023-09-01 |
| Primary Completion | 2028-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 400 participants in total. It began in 2023-09-01 with a primary completion date of 2028-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of this study is to evaluate the effectiveness of the CAMMA intervention in reducing psychological distress among family caregivers of adults with chronic conditions in Thailand. Psychological distress is operationalized as depressive symptoms, anxiety symptoms, and perceived stress.
Eligibility Criteria
Inclusion Criteria: 1. Adult (age 18 +) family caregiver (CG) 2. Has a minimum of 4 months of experience as a caregiver and provides at least 4 hours a day of care to the care recipient (CR); 3. Access to a mobile device with internet access Exclusion Criteria: * Caregiver who refuses to provide informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06722287 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Depressive Symptoms, Generalized Anxiety, or Psychological Stress. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06722287 currently recruiting?
Yes, NCT06722287 is actively recruiting participants. Contact the research team at hchen@bwh.harvard.edu for enrollment information.
Where is the NCT06722287 trial being conducted?
This trial is being conducted at Bangkok, Thailand.
Who is sponsoring the NCT06722287 clinical trial?
NCT06722287 is sponsored by Brigham and Women's Hospital. The trial plans to enroll 400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.